Laryngoscopy Methods for Neonatal Respiratory Distress Syndrome
(VID LISA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Many preterm babies born between 22-28+6 weeks' estimated gestational age (EGA) need surfactant, a medicine that helps the lungs. The goal of the study is to compare the use of video-based visualization to direct visualization during a procedure called less invasive surfactant administration (LISA). The main questions the study aims to answer are: 1) does one method of visualization have a increased rate of giving the medicine successfully on the first attempt? 2) what benefits are there of each method?
Who Is on the Research Team?
Chokshi, MD
Principal Investigator
UT Southwestern
Shalini Ramachandran, MD
Principal Investigator
UT Southwestern
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo less invasive surfactant administration using either video or direct laryngoscopy
Follow-up
Participants are monitored for safety and effectiveness after surfactant administration
What Are the Treatments Tested in This Trial?
Interventions
- Direct Laryngoscopy
- Video Laryngoscopy
How Is the Trial Designed?
2
Treatment groups
Active Control
A video laryngoscopy will be used to visualize the vocal cords and place the LISA catheter for surfactant administration
Direct laryngoscopy (no camera) will be used to visualize the vocal cords and place the LISA catheter for surfactant administration
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.